Xenon Pharmaceuticals Inc.
XENE· Nasdaq
XENEXenon Pharmaceuticals Inc.
Filed May 12, 2015 · 10-Q · 42 days after period end · 0001564590-15-004083
| Metric | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|
| Revenue | $4.01M | $5.00M | $5.39M |
| Net Income | -$9.16M | $1.37M | — |
| EPS Diluted | -$0.64 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenon Pharmaceuticals Inc. · CIK 1582313 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 12, 2015 · 42 d after period end
